0001193125-13-030969.txt : 20150115 0001193125-13-030969.hdr.sgml : 20150115 20130131064108 ACCESSION NUMBER: 0001193125-13-030969 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20130131 FILER: COMPANY DATA: COMPANY CONFORMED NAME: KALOBIOS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001293310 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770557236 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 442 LITTLEFIELD AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650.243.3100 MAIL ADDRESS: STREET 1: 442 LITTLEFIELD AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 CORRESP 1 filename1.htm Company Withdrawal of Request for Acceleration of Effective Date

January 31, 2013

 

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F. Street, N.E.

Washington, D.C. 20549

Attention: Jeffrey Riedler

 

Re:   Withdrawal of Request for Acceleration of Effective Date
KaloBios Pharmaceuticals, Inc.
Registration Statement on Form S-1 (File No. 333-184299)

 

Dear Mr. Riedler:

 

On January 30, 2013, KaloBios Pharmaceuticals, Inc. (the “Registrant”) filed a letter with the Securities and Exchange Commission (the “SEC”) via Edgar. The letter requested that, pursuant to Rule 461 under the Securities Act of 1933, as amended, the SEC accelerate the effective date of the above-referenced Registration Statement on Form S-1 (File No. 333-184299). The Registrant hereby requests to withdraw such acceleration request in order to submit a new acceleration request.

 

Sincerely,

KaloBios Pharmaceuticals, Inc.

By:

  

/s/ David W. Pritchard

  David W. Pritchard
  President and Chief Executive Officer
 CORRESP 2 filename2.htm Underwriter Withdrawal of Request for Acceleration of Effective Date

Leerink Swann LLC

One Federal Street, 37th Floor

Boston, MA 02110

 

January 31, 2013

 

VIA EDGAR

 

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Jeffrey Riedler

 

  Re:   Withdrawal of Request for Acceleration of Effective Date

KaloBios Pharmaceuticals, Inc.

Registration Statement on Form S-1 (File No. 333-184299)

 

Dear Mr. Riedler:

 

On January 30, 2013, we, as the Representative of the several underwriters, filed a letter with the Securities and Exchange Commission via EDGAR requesting, pursuant to Rule 461 under the Securities Act of 1933, as amended, the acceleration of the effective date of the above-referenced Registration Statement on Form S-1 (File No. 333-184299) so that it may be declared effective on January 30, 2013, at 4:00 p.m. Eastern Time, or as soon thereafter as practicable. We hereby withdraw such acceleration request.

 

[Signature Page Follows]

Very truly yours,

 

LEERINK SWANN LLC

As Representative of the several Underwriters

By:   LEERINK SWANN LLC
By   /s/ Bryan Giraudo
 

Name: Bryan Giraudo

Title: Managing Director

 

[Signature Page to Withdrawal of Acceleration Request]